Homepage | Thorax
Thorax is a Plan S compliant Transformative Journal.. Thorax is one of the world's leading respiratory medicine journals, publishing clinical and experimental research articles on respiratory medicine, paediatrics, immunology, pharmacology, pathology, and surgery.Thorax seeks to publish significant advances in scientific understanding, which are …
Current Issue | Thorax
3 天之前 · New management pathways for follow-up of CPAP-treated sleep apnoea patients including digital medicine and multimodal telemonitoring (12 December, 2024 ...
Inhaled corticosteroids and major cardiovascular events in people …
2 天之前 · Background Whether inhaled corticosteroids (ICSs) reduce major adverse cardiovascular events (MACEs) in people with chronic obstructive pulmonary disease (COPD) is debated. Objectives To establish, within people with COPD, (1) whether ICS reduced MACE rates (acute coronary syndrome (ACS), heart failure (HF), ischaemic strokes or cardiovascular-specific death) compared with long-acting ...
Corticosteroid therapy for treating acute exacerbation of …
2 天之前 · Introduction Acute exacerbation of interstitial lung disease (AE-ILD) often results in death and poses significant challenges in clinical management. While corticosteroids are frequently employed, the optimal regimen and their clinical efficacy remain uncertain. To address this knowledge gap, we undertook a systematic review to evaluate the impact of steroid therapy on clinical outcomes in ...
Online First - Thorax
6 天之前 · Associations of pulmonary microvascular blood volume with per cent emphysema and CT emphysema subtypes in the community: the MESA Lung study
Comparative estimate of glucose-lowering therapies on risk of …
Background Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are treatments for type 2 diabetes (T2D). Beyond glucose-lowering and cardiorenal protection, these drugs may protect against pneumonia and sepsis. Aims This study assesses the impact of SGLT2i and GLP …
Current Issue - Thorax
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site.
Authors | Thorax
When publishing in Thorax, authors choose between three licence types – exclusive licence granted to BMJ, CC-BY-NC and CC-BY (Creative Commons open access licences require payment of an article processing charge).As an author you may wish to post your article in an institutional or subject repository, or on a scientific social sharing network.
Air pollution and respiratory health in patients with COPD: should …
Methods We enrolled a panel of 76 patients with COPD and continuously measured their personal exposure to particles and gaseous pollutants and location with portable monitors for 134 days on average. We collected daily health information related to respiratory symptoms through diary cards and peak expiratory flow (PEF). Mixed-effects models were applied to quantify the relationship between ...
About - Thorax
Thorax is BMJ's flagship respiratory medicine journal and has an open access companion journal, BMJ Open Respiratory Research.For information about the Thorax editorial team and the joint Editors-in-Chief (Mark Griffiths, Cecilia O'Kane & Jennifer …